PEGylation-based strategy to identify pathways involved in the activation of apoptotic BAX protein
Yu-Jing Lan1, Yu-Ting Wang1, Chien-Lun Hung1
1Department of Chemistry, National Tsing Hua University, Hsinchu, Taiwan.
Background:
BAX activation is a crucial step for commitment to apoptosis. Several activators, such as BimBH3-based therapeutic peptides and cleaved Bid (cBid) protein, can trigger BAX-mediated apoptosis, but it is unclear whether they proceed through the same pathway.
Methods:
Here we utilize PEGylation-based approach, which is shown to efficiently shield individual binding grooves in BAX from activators, to investigate and reveal that the activators take different routes to induce BAX-mediated apoptosis. Various spectroscopic/biochemical tools, including electron spin resonance, circular dichroism, fluorescence recovery after photobleaching, and label-transfer assay, were employed to reveal details in the processes.
Results:
We observe a key mutant BAX 164-PEG that acts differently in response to cBid and BimBH3 stimuli. While BimBH3 directly interacts with the trigger groove (TG) to induce the conformational changes in BAX that includes the release of α9 from the canonical groove (CG) and oligomerization, cBid engages with CG and works with mitochondrial lipids to fully activate BAX.
Conclusion:
PEGylation-based approach is proven useful to shield individual binding grooves of BAX from apoptotic stimuli. Groove engagement in CG of BAX is required for a full cBid-induced BAX activation. This study has identified differences in the pathways involved during the initiation of BAX activation by full-length cBid protein versus synthetic BimBH3-based peptides.
General Significance:
Our finding is potentially valuable for therapeutic application as the pore-forming activity of 164-PEG is independent from the cBid-mediated apoptotic pathways, but can be administrated by the synthetic short peptides.
Insights
This study reveals that BimBH3 peptides and cleaved Bid (cBid) protein activate BAX-mediated apoptosis through distinct pathways. A novel PEGylation approach differentiated these routes, showing BimBH3 targets the trigger groove and cBid engages the canonical groove.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- BAX activation is critical for initiating apoptosis.
- The precise mechanisms by which different BAX activators, such as BimBH3 peptides and cleaved Bid (cBid), induce apoptosis are not fully understood.
Purpose of the Study:
- To investigate and differentiate the molecular pathways utilized by BimBH3 peptides and cBid protein to activate BAX.
- To explore the utility of a PEGylation-based approach in dissecting BAX activation mechanisms.
Main Methods:
- Utilized a PEGylation-based strategy to selectively shield binding grooves on BAX.
- Employed spectroscopic and biochemical techniques including electron spin resonance, circular dichroism, fluorescence recovery after photobleaching, and label-transfer assays.
Main Results:
- A BAX mutant (164-PEG) exhibited differential responses to cBid and BimBH3.
- BimBH3 directly binds the trigger groove (TG), causing α9 release from the canonical groove (CG) and oligomerization.
- cBid interacts with the CG and requires mitochondrial lipids for full BAX activation.
Conclusions:
- The PEGylation approach effectively differentiates BAX activation pathways.
- Canonical groove (CG) engagement is essential for cBid-mediated BAX activation.
- Identified distinct initiation pathways for BAX activation by cBid versus BimBH3 peptides.
More Related Videos
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
The Extrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...


